145 results on '"van Pesch, Vincent"'
Search Results
2. EEG Responses to Upper Limb Pinprick Stimulation in Acute and Early Subacute Motor and Sensorimotor Stroke
3. Long-term follow up of alemtuzumab-treated patients: a retrospective study in a Belgian tertiary care center
4. Reliability and External Validity of Digital Passive Gait Tracking in MS (P6-6.008)
5. Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study
6. Évolution des troubles cognitifs dans la SEP : des trajectoires hétérogènes ?
7. Influence of a pro-inflammatory stimulus on the miRNA and lipid content of human dental stem cell-derived extracellular vesicles and their impact on microglial activation
8. MicroRNAs dysregulated in multiple sclerosis affect the differentiation of CG-4 cells, an oligodendrocyte progenitor cell line
9. Impact of calcitriol and PGD2-G-loaded lipid nanocapsules on oligodendrocyte progenitor cell differentiation and remyelination
10. Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis – a multicentre study
11. Cognitive trajectories in relapsing-remitting multiple sclerosis: Evidence of multiple evolutionary trends
12. B cell depletion therapy does not resolve chronic active multiple sclerosis lesions
13. Disability accrual in primary and secondary progressive multiple sclerosis
14. Patient-reported outcome measurements in a selective cohort of relapsing–remitting multiple sclerosis patients: relationships with physical disability, cognitive impairment, and MRI-derived metrics
15. Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis
16. Aglycosylated extracellular loop of inwardly rectifying potassium channel 4.1 (KCNJ10) provides a target for autoimmune neuroinflammation
17. Comparative effectiveness in multiple sclerosis: A methodological comparison
18. Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis
19. Usefulness of serum neurofilament light in the assessment of neurologic outcome in the pediatric population: a systematic literature review
20. B-Cell Depletion Therapy Does Not Resolve Chronic Active Multiple Sclerosis Lesions
21. Diagnosis and classification of optic neuritis
22. Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry
23. Alzheimer disease’s cerebrospinal fluid biomarkers differences between immigrants and natives in a Belgian memory clinic
24. Neurofilaments contribution in clinic: state of the art
25. Epidemiology, clinical presentation, treatment, and outcome of neurosarcoidosis: A mono-centric retrospective study and literature review
26. Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis
27. Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network
28. Machine-learning-based prediction of disability progression in multiple sclerosis: an observational, international, multi-center study
29. Validation of the French version of the Multiple Sclerosis Intimacy And Sexuality Questionnaire-19: A preliminary study
30. Prediction of relapse activity when switching to cladribine for multiple sclerosis
31. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial
32. Confirmed disability progression as a marker of permanent disability in multiple sclerosis
33. Molecular Mechanisms of Immunosenescene and Inflammaging: Relevance to the Immunopathogenesis and Treatment of Multiple Sclerosis
34. Clinical usefulness of the CSF β-amyloid Aβ1-42/Aβ1-40 ratio for Alzheimer’s disease diagnosis: a retrospective study in a Belgian academic hospital
35. Machine-Learning-Based Prediction of Disability Progression in Multiple Sclerosis: An Observational, International, Multi-Center Study
36. Corrigendum to Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression: [Computer Methods and Programs in Biomedicine, Volume 208, (September 2021) 106180]
37. Long-term outcomes in patients presenting with optic neuritis: Analyses of the MSBase registry
38. Comment on “Paraneoplastic encephalomyelitis revealing burned-out seminoma”: confirmed case of anti-Kelch-like protein-11 encephalomyelitis
39. Prediction of multiple sclerosis outcomes when switching to ocrelizumab
40. Mechanism of Cellular Formation and In Vivo Seeding Effects of Hexameric β-Amyloid Assemblies
41. Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression
42. Bing–Neel syndrome hidden by multiple sclerosis, a challenging overlay of diseases
43. Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis
44. Extracellular vesicles for the treatment of central nervous system diseases
45. Cutaneous diseases related to a hyperactive T-cell response in ocrelizumab-treated multiple sclerosis patients
46. Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience
47. Effects of prolonged-release fampridine on multiple sclerosis-related gait impairments. A crossover, double-blinded, placebo-controlled study
48. Needs and Experiences of Children and Adolescents with Pediatric Multiple Sclerosis and Their Caregivers: A Systematic Review
49. Variability of the Response to Immunotherapy Among Sub-groups of Patients With Multiple Sclerosis (4107)
50. Disability Accrual in Primary Progressive & Secondary Progressive Multiple Sclerosis (2901)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.